Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GlobeNewswire
REDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage..
REDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage..
*NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients*
*Aarhus, Denmark, 11 June..
A new study published in Science Translational Medicine finds that most surgical site infections may actually be caused by bacteria..